Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥149.8bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥198.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥153.6bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥4.1bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥19.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥7.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥23.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥4.2bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥21.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥2.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥15.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥15.3bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥351.3bnat 2023-12-31Cons.Assets
Total assets¥322.9bnat 2023-03-31Cons.Assets
Total assets¥331.4bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥91.4bnat 2023-12-31Cons.Liabilities
Total liabilities¥67.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥259.9bnat 2023-12-31Cons.Net assets
Net assets / equity¥255.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥255.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥49.6bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥48.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥17.062023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-19.682023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.622022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.572022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥17.042023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥89.332022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥90.62022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio73.7%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥130m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥130m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥5.9bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2023-04-01 → 2023-12-31¥40.9bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2023-04-01 → 2023-12-31¥40.7bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥129m
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.3bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue2023-04-01 → 2023-12-31¥48.3bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue external2023-04-01 → 2023-12-31¥48.3bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥0
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentsegment profit2023-04-01 → 2023-12-31¥888m
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2023-04-01 → 2023-12-31¥60.7bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2023-04-01 → 2023-12-31¥60.7bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥149.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥149.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥130m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥10.0bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥122m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥122m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥5.6bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue2022-04-01 → 2022-12-31¥51.8bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue external2022-04-01 → 2022-12-31¥51.6bn
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥122m
jpcrp040300-q3r_E00836-000Fine Chemicals Business Unitreportable segmentsegment profit2022-04-01 → 2022-12-31¥9.5bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue external2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥0
jpcrp040300-q3r_E00836-000Life Science Business Unitreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.5bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue2022-04-01 → 2022-12-31¥54.8bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentrevenue external2022-04-01 → 2022-12-31¥54.8bn
jpcrp040300-q3r_E00836-000Mobility And Imaging Business Unitreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥153.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥153.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥122m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥24.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 387
ItemContextValueUnit
Valuation difference on available for sale securitiesCurrentQuarterInstant13616000000JPY
Foreign currency translation adjustmentPrior1YearInstant17331000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant21616000000JPY
Remeasurements of defined benefit plansPrior1YearInstant473000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant420000000JPY
Valuation and translation adjustmentsPrior1YearInstant25828000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant35653000000JPY
Non controlling interestsPrior1YearInstant1008000000JPY
Non controlling interestsCurrentQuarterInstant978000000JPY
Net assetsPrior1YearInstant255027000000JPY
Net assetsCurrentQuarterInstant259911000000JPY
Liabilities and net assetsPrior1YearInstant322858000000JPY
Liabilities and net assetsCurrentQuarterInstant351294000000JPY
Net salesPrior1YTDDuration153627000000JPY
Net salesCurrentYTDDuration149753000000JPY
Cost of salesPrior1YTDDuration100640000000JPY
Cost of salesCurrentYTDDuration104343000000JPY
Gross profitPrior1YTDDuration52986000000JPY
Gross profitCurrentYTDDuration45409000000JPY
Selling general and administrative expensesPrior1YTDDuration33924000000JPY
Selling general and administrative expensesCurrentYTDDuration41298000000JPY
Operating incomePrior1YTDDuration19062000000JPY
Operating incomeCurrentYTDDuration4111000000JPY
Interest income noiPrior1YTDDuration381000000JPY
Interest income noiCurrentYTDDuration585000000JPY
Dividends income noiPrior1YTDDuration852000000JPY
Dividends income noiCurrentYTDDuration948000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration-JPY
Equity in earnings of affiliates noiCurrentYTDDuration89000000JPY
Foreign exchange gains noiPrior1YTDDuration517000000JPY
Foreign exchange gains noiCurrentYTDDuration1411000000JPY
Other noiPrior1YTDDuration611000000JPY
Other noiCurrentYTDDuration803000000JPY
Non operating incomePrior1YTDDuration2362000000JPY
Non operating incomeCurrentYTDDuration3837000000JPY
Interest expenses noePrior1YTDDuration95000000JPY
Interest expenses noeCurrentYTDDuration131000000JPY
Equity in losses of affiliates noePrior1YTDDuration47000000JPY
Equity in losses of affiliates noeCurrentYTDDuration-JPY
Other noePrior1YTDDuration287000000JPY
Other noeCurrentYTDDuration345000000JPY
Non operating expensesPrior1YTDDuration430000000JPY
Non operating expensesCurrentYTDDuration476000000JPY
Ordinary incomePrior1YTDDuration20994000000JPY
Ordinary incomeCurrentYTDDuration7473000000JPY
Gain on change in equity eiPrior1YTDDuration123000000JPY
Gain on change in equity eiCurrentYTDDuration-JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration479000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration170000000JPY
Gain on sales of investment securities eiPrior1YTDDuration413000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass